Literature DB >> 9358283

Sarcomatous and adenocarcinoma cell lines from the same nodule of cholangiocarcinoma.

M Enjoji, H Sakai, H Nawata, K Kajiyama, M Tsuneyoshi.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9358283     DOI： 10.1007/s11626-997-0125-z

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  3 in total

1.  Development of human intrahepatic peribiliary glands. Histological, keratin immunohistochemical, and mucus histochemical analyses.

Authors:  T Terada; Y Nakanuma
Journal:  Lab Invest       Date:  1993-03       Impact factor: 5.662

2.  An immunohistochemical study of sarcomatoid liver carcinomas.

Authors:  J Haratake; A Horie
Journal:  Cancer       Date:  1991-07-01       Impact factor: 6.860

3.  Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases.

Authors:  T Nakajima; Y Tajima; I Sugano; K Nagao; Y Kondo; K Wada
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860
  3 in total
  10 in total

1.  Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells.

Authors:  M Enjoji; K Kotoh; H Iwamoto; M Nakamuta; H Nawata
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

2.  Integrins: utility as cell type- and stage-specific markers for hepatocellular carcinoma and cholangiocarcinoma.

Authors:  M Enjoji; H Sakai; M Nakashima; H Nawata
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

3.  In vitro and in vivo study of GSK2830371 and RG7388 combination in liver adenocarcinoma.

Authors:  Chiao-En Wu; Chiao-Ping Chen; Yi-Ru Pan; Shih-Ming Jung; John Wen-Cheng Chang; Jen-Shi Chen; Chun-Nan Yeh; John Lunec
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 4.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

5.  A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma.

Authors:  Sebastian Lange; Johanna Lampe; Sascha Bossow; Martina Zimmermann; Wolfgang Neubert; Michael Bitzer; Ulrich M Lauer
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

6.  Transforming growth factor-alpha induces the differentiation of sarcomatoid cholangiocarcinoma cells.

Authors:  M Enjoji; M Nakashima; M Nakamuta; H Nawata
Journal:  Jpn J Cancer Res       Date:  2000-02

Review 7.  Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type.

Authors:  Meng-Shin Shiao; Khajeelak Chiablaem; Varodom Charoensawan; Nuttapong Ngamphaiboon; Natini Jinawath
Journal:  Front Genet       Date:  2018-08-15       Impact factor: 4.599

8.  LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.

Authors:  Wei Zhao; Jing Zhao; Xiao Guo; Yujie Feng; Bingyuan Zhang; Lantian Tian
Journal:  BMC Cancer       Date:  2021-02-08       Impact factor: 4.430

9.  Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma.

Authors:  Zhuo Liu; Kunyan Zhou; Jian Zeng; Xin Zhou; Huanyu Li; Ke Peng; Xiang Liu; Feng Li; Bin Jiang; Ming Zhao; Tiexiang Ma
Journal:  Oncol Rep       Date:  2022-07-20       Impact factor: 4.136

10.  Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.

Authors:  Xiao-Yong Huang; Chi Zhang; Jia-Bin Cai; Guo-Ming Shi; Ai-Wu Ke; Zhao-Ru Dong; Peng-Fei Zhang; Jia Fan; Bao-Gang Peng; Jian Zhou
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.